Trademark Overview
On Tuesday, June 2, 2026, a trademark application was filed for RE-AIM with the United States Patent and Trademark Office. The USPTO has given the RE-AIM trademark a serial number of 79454035. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 9, 2026. This trademark is owned by Re-Aim Therapeutics Ltd. The RE-AIM trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals; therapeutics; pharmaceuticals and therapeutics for the treatment of autoimmune diseases; pharmaceuticals and therapeutics for the treatment of inflammatory diseases and conditions; pharmaceuticals and therapeutics for the treatment of irritable bowel disease, metabolic disorders, psoriasis, psoriatic arthritis, hidradenitis suppurativa and ankylosing spondylitis.